Minimal-trauma fracture in women with breast cancer surviving for at least 5 years from diagnosis
- 30 October 2014
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 26 (2) , 795-800
Abstract
Minimal-trauma fracture is an important issue in breast cancer survivors, especially rib fracture. The likelihood of fracture is affected by menopausal status and a diagnosis of osteoporosis prior to breast cancer. Most women reported at least one assessment of bone mineral density. We have investigated the self-reported frequency and pattern of minimal-trauma fracture (MTF) in breast cancer (BC) survivors at least 5 years from diagnosis, along with the use of bone mineral density (BMD) assessment. This study was carried out within the Bupa Health Foundation Health and Wellbeing After Breast Cancer Study which is a questionnaire-based prospective cohort study of 1683 women diagnosed with their first invasive breast cancer between 2004 and 2006 and followed for at least 5 years. One thousand two hundred and five women, who remained free of recurrence or new breast cancer, completed the fifth annual follow-up. One hundred sixty-four (13.6 %) reported at least one MTF. Rib fracture was the most common (52 fractures in 46 women). Compared with women who remained pre-/peri-menopausal, either being postmenopausal at diagnosis (OR 3.53, 95 % Confidence Interval (CI) 1.09–11.44, p = 0.036) or changing from pre- to postmenopausal during follow-up (OR 3.97, 95 % CI 1.21–13.10, p = 0.023) was associated with a higher likelihood of fracture, as was having a diagnosis of osteoporosis at the time of diagnosis (OR 1.74, 95 % CI 1.00–2.99, p = 0.047). Most women (64.9 %) reported at least one BMD assessment. Overall MTF is a problem for breast cancer survivors, with rib fracture a particular issue for women in our study. Both pre-existing osteoporosis and being postmenopausal are risk factors for subsequent MTF in women treated for breast cancer. Clinicians need to be mindful of fracture prevention medication in these groups.Keywords
This publication has 21 references indexed in Scilit:
- Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosisMenopause, 2013
- Fracture risk in women with breast cancer: A population-based studyJournal of Bone and Mineral Research, 2012
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2011
- Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patientsOsteoporosis International, 2010
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast CancerJournal of Clinical Oncology, 2010
- Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancerBMC Cancer, 2008
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230Journal of Clinical Oncology, 2008
- Incidence of Hip and Other Osteoporotic Fractures in Elderly Men and Women: Dubbo Osteoporosis Epidemiology StudyJournal of Bone and Mineral Research, 2004
- American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast CancerJournal of Clinical Oncology, 2003
- Spontaneous Radiation-Induced Rib Fractures in Breast Cancer Patients Treated with Postmastectomy Irradiation—A Clinical Radiobiological Analysis of the Influence of Fraction Size and Dose-Response Relationships on Late Bone DamageActa Oncologica, 1988